Conceptus Inc.

Mr. Sieczkarek was appointed as our President and Chief Executive Officer and to the Board of Directors in April 2003. Mr. Sieczkarek served as President, Americas, of Bausch and Lomb, Inc. from July 2001 to January 2003, as Corporate Vice President and President Europe, Middle East and Africa Region from 1999 to 2001 and held positions of increasing responsibility at various divisions of Bausch and Lomb from 1995 to 1999. Prior to joining Bausch and Lomb, Mr. Sieczkarek was Vice President and Chief Financial Officer of KOS Pharmaceuticals from 1993 to 1995. From 1980 to 1993, Mr. Sieczkarek held executive level positions in Finance and Commercial Operations with several Bristol Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur. Mr. Sieczkarek currently serves on the Board of Directors of Thermage, Inc., a public medical device company, where he also participates on its Audit Committee. Mr. Sieczkarek holds a B.S. in Accounting from the State University of New York at Buffalo and a M.B.A. degree in Finance from Canisius College. The Board of Directors has determined that Mr. Sieczkarek is not "independent" as that term is defined in the Nasdaq Marketplace Rules.

Mr. Lichtwardt joined Conceptus as Executive Vice President, Treasurer and Chief Financial Officer in November 2003 and was promoted to Executive Vice President, Operations, Treasurer and Chief Financial Officer in April 2008. From 2000 to 2002, he was Executive Vice President, Finance, Chief Financial Officer and Corporate Secretary of Innoventry, Inc., a financial services company. From 1993 to 2000, Mr. Lichtwardt was Vice President, Finance, Chief Financial Officer and Treasurer of Ocular Sciences, Inc., a worldwide developer and marketer of soft contact lenses. Prior to his employment with Ocular Sciences, Mr. Lichtwardt, from 1989 to 1993, held senior management positions in various divisions of Allergan Inc. In addition to these positions, Mr. Lichtwardt has held various financial positions at AST Research, Inc. and at divisions of American Hospital Supply Corporation. He holds a B.B.A. degree from the University of Michigan and M.B.A. degree from Michigan State University.

Mr. Cote joined Conceptus as Vice President of Sales in April 2004. He currently serves Conceptus as the Executive Vice President of Global Sales and Business Development. From 2003 to 2004, Mr. Cote was Senior Director of Sales, Gynecology Division at American Medical Systems. From 2000 to 2001, he served as President and Chief Executive Officer of Collagenesis, a developer and marketer of products derived from reengineered and processed human tissue. Prior to Collagenesis, Mr. Cote was Director of Sales and Marketing for Influence, a medical company developing a treatment for incontinence, from 1996 to 2000 and held various sales positions at Indigo Medical and Osbon Medical Systems, from 1990 to 1996. He holds a B.S. degree in Business Administration from California State University at Sacramento.

Mr. Uecker was most recently with RITA Medical Systems, where he was Chief Technology Officer from January 2004 until January 2007. While at RITA, he was instrumental in growing the business over 200%, culminating in the sale of RITA to Angio Dynamics. Mr. Uecker’s background includes extensive experience in product development, R&D, operations and business development in a variety of medical device markets. He is a named inventor on 43 US patents and has led the development and launch of more than a dozen medical devices in his career. He received a Bachelor and Master’s degree in Electrical and Computer Engineering from the University of California at Santa Barbara.

Mr. Roeck joined Conceptus as Vice President of International in September of 2007 and is responsible for all aspects of the Company's international operations. From 2003 to 2007 Mr. Roeck was with VNUS Medical Technologies as the Senior Director of International Sales and Marketing where he managed both direct sales and distributor growth of over 30%. From 2000 to 2003 Mr. Roeck held the position of Business to Business Account Executive with Eli Lilly and Company. Prior to his employment with Eli Lilly and Company, he was residing overseas as the Regional Sales Manager in Asia/Middle East and later Europe for Palco Labs, a medical device manufacture. Mr. Roeck received a Bachelor's degree in International Business from California State University San Jose and attended Thunderbird, The American Graduate School of International Management.

Mr. Sloan joined the Conceptus management team in February 2008 and serves as the Vice President of Professional Marketing and Research and Development. In this role, he oversees all new product development activities, sits on the new business development committee and is responsible for the clinician facing marketing strategy. Prior to joining Conceptus, he was a Director of Marketing at Boston Scientific, overseeing their women's health portfolio. Over his eleven years with Boston Scientific, Mr. Sloan held positions with increasing responsibility in both sales and marketing in the urology and gynecology specialties. Mr. Sloan received his undergraduate degree from Penn State University and Masters in Business from Lehigh University.

Peter L. Wilson was appointed to the Company's Board of Directors in December 2001 and was appointed as the lead independent director in November 2002. Mr. Wilson currently serves on the board of directors of ArthroCare Corporation. Mr. Wilson was President and Chief Executive Officer of Patient Education Systems from 1995 to 1998. Between 1992 and 1994, Mr. Wilson was an independent consultant in healthcare business development and marketing. From 1972 to 1992, Mr. Wilson worked for Proctor & Gamble / Richardson Vicks, where he held various positions as President of Richardson Vicks, Vice President/General Manager of Proctor & Gamble Vicks Healthcare, President/General Manager of the Vidal Sassoon Division and President/General Manager of the Personal Care Division. Mr. Wilson holds a B.A. from Princeton University and a M.B.A. in Marketing from Columbia University.

Thomas F. Bonadio was appointed to the Company's Board of Directors in September 2003. Mr. Bonadio is the founder and managing partner of The Bonadio Group, an independent provider of accounting, business advisory and financial services in the upstate New York area and a top 100 certified public accounting firm in the United States. He founded this business in 1978, following seven years with Arthur Andersen & Co. Mr. Bonadio is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He holds a B.B.A. from St. John Fisher College, and is the past chairman of St. John Fisher College's Board of Trustees.

Mr. Bishop joined us as Chief Executive Officer and as a director in April 2002. Mr. Bishop served as President and a director of Vysis, Inc., a genomic disease management company that was acquired by Abbott Laboratories, from 1993 to 2002 and as Chief Executive Officer from 1996 to 2002. From 1991 until 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company, and, from 1987 until 1991, of Source Scientific Systems, a biomedical instrument manufacturing company. From 1984 to 1986, Mr. Bishop was President and Chief Operating Officer of Gen-Probe, Inc. From 1968 to 1984, Mr. Bishop held various management positions with American Hospital Supply Company and its affiliates, including a three-year assignment in Japan as an Executive Vice President and Chief Executive Officer of International Reagents Corp., a joint venture between American Hospital Supply Company and Green Cross Corporation. Mr. Bishop currently serves as a director of Conceptus, Inc. and as a member of the Board of the Biotechnology Industry Organization (BIO) and the BIO Health Section Governing Board.

Paul LaViolette is Chief Operating Officer at Boston Scientific. He is responsible for all the Company's business units, worldwide commercial activities, global quality and manufacturing activities. In addition, Paul shares responsibility for the Company's clinical, regulatory, research and development functions. Paul joined Boston Scientific in 1994 as President of Boston Scientific International. In 1995, he became Group President for the nonvascular businesses, which included Microvasive Endoscopy and Microvasive Urology. In 1998, he again joined Boston Scientific International as its President to help strengthen and stabilize the organization. In 2000, Paul added Group President responsibilities for the Scimed, EP Technologies and Target divisions, and in 2001 also took on the role of President of Scimed. Prior to his latest appointment, Paul was Senior Vice President and Group President responsible for the Interventional Cardiology, Peripheral Interventions, Vascular Surgery, Electrophysiology and Neurovascular businesses. He was also responsible for Boston Scientific International, Corporate Sales and National Accounts, Healthcare Strategies and Programs, and Government Affairs. Paul currently serves on the Board of Directors of AdvaMed (Advanced Medical Technology Association). Before joining Boston Scientific, Paul spent 10 years with C. R. Bard, where he served as President of Bard's USCI Division from 1993 to 1994 and its USCI Angioplasty Division from 1991 to 1993. Previously, he held several marketing positions at Bard, including Vice President of Marketing for USCI. Prior to joining Bard, Paul was with the Kendall Company's Hospital Products Division. Paul graduated from Fairfield University, and earned an M.B.A. from Boston College.